Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    My account
    Logout
AI 90-DAY FORECAST
BULLISH SIGNAL DETECTED
██.█% Sign up free to reveal

Gsk Plc (GSK) AI Forecast

Our AI detected a significant signal for Gsk Plc. Create a free account to see the exact price target.

✓ Free account • ✓ 30-day free trial

$GSK Bullish Signal Full forecast available
Sign Up Free

Gsk Plc (GSK) Stock Forecast 2025

Gsk Plc (GSK) AI Stock Price Forecast & Investment Analysis

Gsk Plc Stock Price Chart and Technical Analysis

Loading chart...

Gsk Plc (GSK) - Comprehensive Stock Analysis & Investment Research

Deep dive into Gsk Plc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on March 26, 2026, 4:43 a.m. (UTC)

Gsk Plc Investment Summary

When evaluating whether Gsk Plc (GSK) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Gsk Plc (GSK) operates within the Life Sciences sector, specifically in the Pharmaceutical Preparations industry. . With a market capitalization of $104 billion, the company is a large-cap stock offering relative stability combined with growth potential.

Financial Performance Analysis

Our comprehensive financial analysis covers Gsk Plc's revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Gsk Plc along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Gsk Plc is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Gsk Plc

Sign Up Free
Corporate Identity

Gsk Plc (Stock Symbol: GSK) is a prominent company operating within the Life Sciences sector, with a specific focus on the Pharmaceutical Preparations industry. The company's shares are publicly traded on the NYSE exchange.

Leadership & Workforce

Detailed information about Gsk Plc's leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Gsk Plc...

Sector & Industry Analysis

In-depth sector dynamics and industry context for Gsk Plc...

Unlock Full Company Profile

Get complete details about Gsk Plc

Sign Up Free
Revenue & Growth Analysis
Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Gsk Plc...

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Gsk Plc...

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Gsk Plc...

Unlock Financial Analysis

Get complete financial metrics for Gsk Plc

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Gsk Plc's AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial →

✓ 30-day free trial • ✓ Cancel anytime

Strategic Market Position

Gsk Plc strategically competes in the highly dynamic Pharmaceutical Preparations marketplace. As a large-cap market participant, the company has established significant competitive advantages and market presence. Large-cap companies typically benefit from brand recognition, operational scale, diverse revenue streams, and the financial resources to invest in research and development, marketing, and strategic acquisitions. This size category attracts substantial institutional ownership and analyst coverage.

Industry Competitive Landscape

Gsk Plc competes within the Life Sciences sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency
Financial Strength & Leverage

Gsk Plc (GSK) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Gsk Plc stock analysis.

Deep dive into Gsk Plc's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Gsk Plc stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Gsk Plc:

Market Cap $104.38B
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Gsk Plc converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Gsk Plc:

Understanding Financial Health Metrics

What these metrics mean: These ratios assess Gsk Plc's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Gsk Plc:

Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Gsk Plc's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Gsk Plc:

Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Gsk Plc uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Gsk Plc:

Understanding Financial Statement Data

What these metrics mean: Key figures from Gsk Plc's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Gsk Plc:

Income Statement
Balance Sheet Highlights (% Of Assets)
Dividend & Shareholder Information
Shares Outstanding 2005M

Latest Gsk Plc Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Gsk Plc (GSK) stock price and investment outlook.

More news available

Sign up free to read all 11 news articles and stay updated on market developments.

Sign Up Free to Read More

Gsk Plc Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of Gsk Plc against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
Aardvark Therapeutics, Inc. AARD ██% $77M x 0.7x
Abbvie Inc. ABBV ██% $366.50B 86.7x 258.1x
Abcellera Biologics Inc. ABCL ██% $1.02B -5.3x 1.1x
Abeona Therapeutics Inc. ABEO ██% $243M 3.4x 1.5x
Abbott Laboratories ABT ██% $182.51B 28.0x 3.5x
Arbutus Biopharma Corp ABUS ██% $872M -8.3x 11.4x
Abvc Biopharma, Inc. ABVC ██% $27M -0.3x 2.4x
Abivax S.A. ABVX ██% $8.69B x x
Acadia Pharmaceuticals Inc ACAD ██% $3.75B 9.6x 3.1x
Adicet Bio, Inc. ACET ██% $65M -0.4x 0.4x
Aclaris Therapeutics, Inc. ACRS ██% $433M -4.5x 4.2x
Acrivon Therapeutics, Inc. ACRV ██% $59M -2.8x 0.5x
Actuate Therapeutics, Inc. ACTU ██% $120M x 11.0x
Accustem Sciences Inc. ACUT ██% $8M x 9.7x
Acurx Pharmaceuticals, Inc. ACXP ██% $12M -0.8x 2.3x
Adagene Inc. ADAG ██% $192M x 5.1x
Adc Therapeutics Sa ADCT ██% $499M -9.2x -1.3x
Adial Pharmaceuticals, Inc. ADIL ██% $2M -0.1x 0.5x
Aditxt, Inc. ADTX ██% $400K 0.0x 0.0x
Addex Therapeutics Ltd. ADXN ██% $8M x x
Aeon Biopharma, Inc. AEON ██% $30M 6.5x x
Agios Pharmaceuticals, Inc. AGIO ██% $1.73B 3.7x 1.5x
Ainos, Inc. AIMD ██% $10M -0.4x 1.0x
Akebia Therapeutics, Inc. AKBA ██% $369M -5.4x 11.3x
Akero Therapeutics, Inc. AKRO ██% $4.38B -8.7x 4.6x
Akari Therapeutics Plc AKTX ██% $6M -2.0x 0.3x
Aldeyra Therapeutics, Inc. ALDX ██% $111M -5.1x 2.5x
Alkermes Plc. ALKS ██% $4.86B 20.1x 2.7x
Allarity Therapeutics, Inc. ALLR ██% $18M -0.2x 1.5x
Alumis Inc. ALMS ██% $2.93B x 9.7x
Alnylam Pharmaceuticals, Inc. ALNY ██% $43.51B 138.7x 55.1x
Altimmune, Inc. ALT ██% $422M -5.7x 1.9x
Alx Oncology Holdings Inc ALXO ██% $268M -0.4x 10.3x
Alzamend Neuro, Inc. ALZN ██% $7M -0.1x 3.4x
Amylyx Pharmaceuticals, Inc. AMLX ██% $1.52B -1.5x 5.0x
Amphastar Pharmaceuticals, Inc. AMPH ██% $893M 9.1x 2.0x
Amarin Corp Plc\Uk AMRN ██% $301M -4.5x 0.7x
Amneal Pharmaceuticals, Inc. AMRX ██% $3.84B 53.3x 194.2x
Anaptysbio, Inc ANAB ██% $1.83B -2.5x 49.2x
Anebulo Pharmaceuticals, Inc. ANEB ██% $41M -4.3x 5.2x
Ani Pharmaceuticals Inc ANIP ██% $1.67B 21.3x 3.1x
Anixa Biosciences Inc ANIX ██% $87M -15.0x 5.8x
Annexon, Inc. ANNX ██% $797M -4.1x 4.9x
Alto Neuroscience, Inc. ANRO ██% $660M x 4.4x
An2 Therapeutics, Inc. ANTX ██% $132M x 2.5x
Annovis Bio, Inc. ANVS ██% $64M -1.0x 3.8x
Apollomics Inc. APLM ██% $38M x x
Apellis Pharmaceuticals, Inc. APLS ██% $2.24B 100.2x 6.1x
Applied Therapeutics, Inc. APLT ██% $15M -0.7x 0.9x
Aprea Therapeutics, Inc. APRE ██% $8M -1.2x 0.7x
Apimeds Pharmaceuticals Us, Inc. APUS ██% $22M x 2.7x
Aptevo Therapeutics Inc. APVO ██% $7M -0.1x 0.4x
Aquestive Therapeutics, Inc. AQST ██% $514M -10.7x 51.0x
Arcturus Therapeutics Holdings Inc. ARCT ██% $201M -7.0x 0.9x
Ardelyx, Inc. ARDX ██% $1.38B -21.3x 8.3x
Arcutis Biotherapeutics, Inc. ARQT ██% $2.69B -6.6x 14.2x
Artelo Biosciences, Inc. ARTL ██% $3M -0.7x 5.3x
Arvinas, Inc. ARVN ██% $693M -4.8x 1.6x
Arrowhead Pharmaceuticals, Inc. ARWR ██% $8.35B 41.3x 14.7x
Aspire Biopharma Holdings, Inc. ASBP ██% $6M x x
Assembly Biosciences, Inc. ASMB ██% $455M -1.5x 2.2x
Ascendis Pharma A/S ASND ██% $13.36B x x
Assertio Holdings, Inc. ASRT ██% $119M -0.2x 1.3x
Atai Beckley N.V. ATAI ██% $1.29B -4.4x 8.1x
Alterity Therapeutics Ltd ATHE ██% $64M x x
Actinium Pharmaceuticals, Inc. ATNM ██% $34M -4.1x 2.4x
Atossa Therapeutics, Inc. ATOS ██% $47M -6.2x 1.2x
Avenue Therapeutics, Inc. ATXI ██% $920K -9.5x 0.3x
Astria Therapeutics, Inc. ATXS ██% $710M -4.7x 3.0x
Aurinia Pharmaceuticals Inc. AUPH ██% $1.90B 6.6x 3.3x
Arrivent Biopharma, Inc. AVBP ██% $966M x 3.1x
Avadel Pharmaceuticals Plc AVDL ██% $2.10B -10.2x 21.4x
Atea Pharmaceuticals, Inc. AVIR ██% $424M -1.5x 1.5x
Avalo Therapeutics, Inc. AVTX ██% $258M -0.1x 3.1x
Axim Biotechnologies, Inc. AXIM ██% $2M x 0.4x
Axsome Therapeutics, Inc. AXSM ██% $8.23B -19.9x 93.2x
Aytu Biopharma, Inc AYTU ██% $27M -0.3x 1.2x
Azitra, Inc. AZTR ██% $4M -0.2x 1.1x
Bridgebio Pharma, Inc. BBIO ██% $13.95B -11.6x -5.4x
Bicara Therapeutics Inc. BCAX ██% $1.21B x 3.0x
Briacell Therapeutics Corp. BCTX ██% $29M -1.7x 1.0x
Bicycle Therapeutics Plc BCYC ██% $325M -6.0x 0.5x
Bioadaptives, Inc. BDPT ██% $140K x 12.2x
Beone Medicines Ltd. BEIGF ██% $36.38B 530.6x 8.8x
Bullfrog Ai Holdings, Inc. BFRG ██% $6M -2.9x 3.0x
Biofrontera Inc. BFRI ██% $10M -0.1x 0.9x
Bausch Health Companies Inc. BHC ██% $1.88B 12.0x 3.5x
Bioharvest Sciences Inc. BHST ██% $99M x 74.3x
Biohaven Ltd. BHVN ██% $1.30B -4.6x 24.9x
Bioage Labs, Inc. BIOA ██% $782M x 2.8x
Bio Essence Corp BIOE ██% $4M x x
Biovie Inc. BIVI ██% $10M -0.6x 0.5x
Bioxytran, Inc BIXT ██% $3M x 5.9x
Biolinerx Ltd. BLRX ██% $12M x x
Belite Bio, Inc BLTE ██% $6.10B x 67.5x
Biomea Fusion, Inc. BMEA ██% $88M -1.6x 3.0x
Biomarin Pharmaceutical Inc BMRN ██% $10.69B 30.6x 1.8x
Bristol Myers Squibb Co BMY ██% $119.88B 17.0x 6.5x
Bristol Myers Squibb Co BMYMP ██% $1.73T 287.0x 93.4x
Benitec Biopharma Inc. BNTC ██% $371M -0.6x 2.0x
Boundless Bio, Inc. BOLD ██% $25M -15.1x 0.3x
Bolt Biotherapeutics, Inc. BOLT ██% $9M -0.3x 0.3x
Bio-Path Holdings, Inc. BPTH ██% $530K 0.0x 3.4x
Bioquest Corp BQST ██% $14M x 2.8x
Barinthus Biotherapeutics Plc. BRNS ██% $22M -0.6x 0.3x
Bespoke Extracts, Inc. BSPK ██% $3M x 171.2x
Bioxcel Therapeutics, Inc. BTAI ██% $35M -0.1x 5.9x
Beyondspring Inc. BYSI ██% $72M 63.8x 1.3x
Calcimedica, Inc. CALC ██% $9M 0.4x 1.5x
Camp4 Therapeutics Corp CAMP ██% $247M -0.1x 5.2x
Can-Fite Biopharma Ltd. CANF ██% $7M x 1.7x
Capricor Therapeutics, Inc. CAPR ██% $1.72B x 5.6x
Carisma Therapeutics Inc. CARM ██% $1M 0.2x 0.0x
Casi Pharmaceuticals, Inc. CASI ██% $5M -1.4x 2.5x
Perspective Therapeutics, Inc. CATX ██% $515M -2.8x 2.5x
Crescent Biopharma, Inc. CBIO ██% $325M -6.5x 1.6x
Cdt Equity Inc. CDT ██% $2M -0.7x 0.5x
Cingulate Inc. CING ██% $78M -0.6x 31.1x
Cell Source, Inc. CLCS ██% $33M x 2917.3x
Clene Inc. CLNN ██% $59M -7.3x 13.9x
Cellectar Biosciences, Inc. CLRB ██% $13M x 1.5x
Clearside Biomedical, Inc. CLSD ██% $4M -2.0x -0.7x
Climb Bio, Inc. CLYM ██% $476M -1.4x 3.0x
Chemomab Therapeutics Ltd. CMMB ██% $10M 10.9x 0.8x
Clearmind Medicine Inc. CMND ██% $2M x x
Compass Pathways Plc CMPS ██% $638M 0.0x 17.0x
Cnbx Pharmaceuticals Inc. CNBX ██% $90K x 0.1x
Cns Pharmaceuticals, Inc. CNSP ██% $2M 0.0x 0.2x
Centessa Pharmaceuticals Plc CNTA ██% $3.79B -11.0x 12.6x
Connect Biopharma Holdings Ltd CNTB ██% $187M x 3.4x
Context Therapeutics Inc. CNTX ██% $245M -1.5x 4.1x
Cocrystal Pharma, Inc. COCP ██% $14M -1.0x 1.8x
Cogent Biosciences, Inc. COGT ██% $5.63B -3.7x 8.8x
Collegium Pharmaceutical, Inc COLL ██% $1.05B 16.8x 3.5x
Corcept Therapeutics Inc CORT ██% $3.58B 36.0x 5.5x
Coya Therapeutics, Inc. COYA ██% $98M -6.8x 2.3x
China Pharma Holdings, Inc. CPHI ██% $3M -0.2x 0.4x
Cumberland Pharmaceuticals Inc CPIX ██% $50M -4.5x 2.0x
Cannapharmarx, Inc. CPMD ██% $3M x 1.9x
Catalyst Pharmaceuticals, Inc. CPRX ██% $2.92B 13.6x 3.1x
Corbus Pharmaceuticals Holdings, Inc. CRBP ██% $146M -2.0x 1.0x
Cormedix Inc. CRMD ██% $524M 3.2x 1.3x
Crinetics Pharmaceuticals, Inc. CRNX ██% $3.47B -15.9x 3.5x
Cervomed Inc. CRVO ██% $37M -0.7x 2.1x
Corvus Pharmaceuticals, Inc. CRVS ██% $1.19B -13.7x 19.5x
Cytomx Therapeutics, Inc. CTMX ██% $912M 29.5x 9.2x
Contineum Therapeutics, Inc. CTNM ██% $460M x 1.8x
Citius Oncology, Inc. CTOR ██% $49M 3.9x 0.8x
Hepion Pharmaceuticals, Inc. CTRVP ██% $20K x 0.0x
Citius Pharmaceuticals, Inc. CTXR ██% $16M -5.3x 0.2x
Cue Biopharma, Inc. CUE ██% $25M -1.2x 0.9x
Cadrenal Therapeutics, Inc. CVKD ██% $13M -11.1x 4.6x
Cv Sciences, Inc. CVSI ██% $6M x 3.6x
Cyclerion Therapeutics, Inc. CYCN ██% $6M -5.2x 0.6x
Cytodyn Inc. CYDY ██% $329M 86.7x 118.9x
Cryoport, Inc. CYRX ██% $419M 5.4x 0.8x
Cytokinetics Inc CYTK ██% $7.68B -9.4x 70.8x
Dare Bioscience, Inc. DARE ██% $20M 2.9x 7.0x
Day One Biopharmaceuticals, Inc. DAWN ██% $2.20B -8.9x 5.0x
Journey Medical Corp DERM ██% $230M 24.1x 8.9x
Diamedica Therapeutics Inc. DMAC ██% $359M -4.2x 7.0x
Dianthus Therapeutics, Inc. /De/ DNTH ██% $4.16B -3.2x 8.4x
Dermata Therapeutics, Inc. DRMA ██% $5M -0.2x 1.3x
Bright Minds Biosciences Inc. DRUG ██% $684M x x
Design Therapeutics, Inc. DSGN ██% $622M -7.6x 2.9x
Dynavax Technologies Corp DVAX ██% $1.82B 88.2x 3.4x
Dogwood Therapeutics, Inc. DWTX ██% $86M -2.9x 1.2x
Dyne Therapeutics, Inc. DYN ██% $3.02B -7.8x 3.1x
Emergent Biosolutions Inc. EBS ██% $417M 7.9x 0.8x
Edesa Biotech, Inc. EDSA ██% $64M -1.3x 4.6x
Eagle Pharmaceuticals, Inc. EGRX ██% $4M 0.4x 0.0x
Pmgc Holdings Inc. ELAB ██% $2M -8.2x 0.2x
Elanco Animal Health Inc ELAN ██% $12.34B 341.6x 1.9x
Eledon Pharmaceuticals, Inc. ELDN ██% $239M x 6.8x
Elite Pharmaceuticals Inc /Nv/ ELTP ██% $408M 15.5x 5.1x
Elicio Therapeutics, Inc. ELTX ██% $188M -1.9x 114.8x
Enliven Therapeutics, Inc. ELVN ██% $1.85B -13.3x 4.0x
Emmaus Life Sciences, Inc. EMMA ██% $930K x 0.2x
Enlivex Ltd. ENLV ██% $261M x 13.7x
Ensysce Biosciences, Inc. ENSC ██% $2M x 1.7x
Enanta Pharmaceuticals Inc ENTA ██% $351M -1.3x 2.8x
Gridai Technologies Corp. ENTO ██% $7M 0.0x 0.3x
Enveric Biosciences, Inc. ENVB ██% $3M -0.1x 0.8x
Evolus, Inc. EOLS ██% $314M -13.1x 56.9x
Essa Pharma Inc. EPIX ██% $9M -2.7x 0.1x
Eupraxia Pharmaceuticals Inc. EPRX ██% $424M x 5.2x
Equillium, Inc. EQ ██% $119M -3.2x 3.8x
Erasca, Inc. ERAS ██% $4.17B -3.1x 12.8x
Ernexa Therapeutics Inc. ERNA ██% $6M x 2.6x
Esperion Therapeutics, Inc. ESPR ██% $643M -4.2x 71.8x
89bio, Inc. ETNB ██% $2.20B -3.5x 4.2x
Eton Pharmaceuticals, Inc. ETON ██% $621M -66.2x 23.8x
Earth Science Tech, Inc. ETST ██% $29M 14.0x 5.1x
Evofem Biosciences, Inc. EVFM ██% $1M 2.6x 0.1x
Edgewise Therapeutics, Inc. EWTX ██% $3.26B -19.7x 6.2x
Fuss Brands Corp. FBDS ██% $2M x 0.0x
Fortress Biotech, Inc. FBIO ██% $91M 22.7x 1.6x
Fortress Biotech, Inc. FBIOP ██% $394M 98.8x 7.1x
Fibrobiologics, Inc. FBLG ██% $18M x 2.9x
Forte Biosciences, Inc. FBRX ██% $311M -11.5x 3.7x
Fibrogen Inc FGEN ██% $35M 0.2x -3.6x
Foghorn Therapeutics Inc. FHTX ██% $276M -3.3x 2468.6x
Amicus Therapeutics, Inc. FOLD ██% $4.48B -8.5x 16.3x
Fulcrum Therapeutics, Inc. FULC ██% $461M -36.1x 1.3x
Galectin Therapeutics Inc GALT ██% $182M -2.4x 204.3x
Gain Therapeutics, Inc. GANX ██% $70M -1.4x 11.9x
Generation Bio Co. GBIO ██% $36M -0.6x 0.7x
Greater Cannabis Company, Inc. GCAN ██% $230K x x
Geron Corp GERN ██% $992M -11.9x 4.4x
Gh Research Plc GHRS ██% $831M x x
Galmed Pharmaceuticals Ltd. GLMD ██% $4M x 0.2x
Galapagos Nv GLPG ██% $1.96B x x
Greenwich Lifesciences, Inc. GLSI ██% $354M -17.2x 162.1x
Galecto, Inc. GLTO ██% $1.59B -2.5x 198.2x
Genelux Corp GNLX ██% $108M -2.8x 9.4x
Genprex, Inc. GNPX ██% $5M -3.2x 5.9x
Gossamer Bio, Inc. GOSS ██% $81M -3.2x 2.7x
Geovax Labs, Inc. GOVX ██% $3M x 0.7x
Structure Therapeutics Inc. GPCR ██% $3.33B -44.0x 2.2x
Grace Therapeutics, Inc. GRCE ██% $69M -3.9x 1.1x
Gri Bio, Inc. GRI ██% $4M -0.1x 0.6x
Galera Therapeutics, Inc. GRTX ██% $3M 0.0x 0.8x
Gsk Plc GSK ██% $104.38B x x
Gt Biopharma, Inc. GTBP ██% $15M x 2.6x
Gyre Therapeutics, Inc. GYRE ██% $634M 64.1x 6.0x
Hutchmed (China) Ltd HCM ██% $2.55B x 2.1x
Hcw Biologics Inc. HCWB ██% $2M x 0.3x
Hepion Pharmaceuticals, Inc. HEPA ██% $590K -0.1x 0.2x
Hutchmed (China) Ltd HMDCF ██% $2.64B x 2.1x
Hookipa Pharma Inc. HOOK ██% $14M -1.0x 0.4x
Hoth Therapeutics, Inc. HOTH ██% $15M -0.5x 1.8x
Werewolf Therapeutics, Inc. HOWL ██% $40M -1.3x 1.4x
Harmony Biosciences Holdings, Inc. HRMY ██% $1.56B 9.9x 1.8x
Heron Therapeutics, Inc. /De/ HRTX ██% $144M -6.4x 10.0x
Hst Global, Inc. HSTC ██% $44M x 35.4x
Tuhura Biosciences, Inc./Nv HURA ██% $101M x 6.0x
Ibio, Inc. IBIO ██% $72M -0.4x 1.3x
Impact Biomedical Inc. IBO ██% $48M x 3.8x
Ideaya Biosciences, Inc. IDYA ██% $2.92B -12.2x 2.9x
Inflarx N.V. IFRX ██% $74M x x
Igc Pharma, Inc. IGC ██% $24M -4.6x 3.2x
Immutep Ltd IMMP ██% $53M x x
Immix Biopharma, Inc. IMMX ██% $454M x 34.3x
Immunome Inc. IMNM ██% $2.29B -2.4x 3.6x
Imunon, Inc. IMNN ██% $10M -0.5x 2.5x
Immuron Ltd IMRN ██% $8M x x
Immuneering Corp IMRX ██% $363M -0.8x 1.7x
Eom Pharmaceutical Holdings, Inc. IMUC ██% $6M x 1.8x
Immunic, Inc. IMUX ██% $163M -0.8x 15.5x
Integrated Biopharma Inc INBP ██% $9M 14.8x 0.5x
Indaptus Therapeutics, Inc. INDP ██% $4M -0.6x 0.9x
Indivior Pharmaceuticals, Inc. INDV ██% $3.60B 17.1x x
Inmed Pharmaceuticals Inc. INM ██% $2M -51.8x 0.2x
Inovio Pharmaceuticals, Inc. INO ██% $106M -0.6x 4.4x
Insmed Inc INSM ██% $30.57B -14.0x 41.4x
Inhibitor Therapeutics, Inc. INTI ██% $15M x 4348.1x
Innoviva, Inc. INVA ██% $1.64B 6.0x 1.4x
Io Biotech, Inc. IOBT ██% $13M -0.7x 14.6x
Ionis Pharmaceuticals Inc IONS ██% $11.38B -14.6x 23.3x
Opus Genetics, Inc. IRD ██% $315M -2.0x 20.5x
Disc Medicine, Inc. IRON ██% $2.37B -18.4x 3.2x
Ironwood Pharmaceuticals Inc IRWD ██% $496M 20.6x 0.7x
International Stem Cell Corp ISCO ██% $1M x 0.4x
Iterum Therapeutics Plc ITRM ██% $9M -0.8x 2.6x
Inventiva S.A. IVA ██% $1.25B x x
Incannex Healthcare Inc. IXHL ██% $39M x 0.5x
Jaguar Health, Inc. JAGX ██% $5M -0.2x 1.0x
Janux Therapeutics, Inc. JANX ██% $819M -63.7x 0.9x
Jazz Pharmaceuticals Plc JAZZ ██% $11.37B 14.3x 2.6x
Jade Biosciences, Inc. JBIO ██% $654M x 2.0x
Johnson & Johnson JNJ ██% $566.39B 21.1x 7.1x
Jupiter Neurosciences, Inc. JUNS ██% $13M x 229.1x
Kala Bio, Inc. KALA ██% $194M -0.5x 33.9x
Kalvista Pharmaceuticals, Inc. KALV ██% $832M -2.6x 48.9x
Kairos Pharma, Ltd. KAPA ██% $13M x 1.7x
Kaya Holdings, Inc. KAYS ██% $24M x x
Kamada Ltd KMDA ██% $473M x x
Kiniksa Pharmaceuticals International, Plc KNSA ██% $3.33B 56.5x 5.9x
Kiora Pharmaceuticals Inc KPRX ██% $7M -2.4x 0.3x
Karyopharm Therapeutics Inc. KPTI ██% $107M -0.6x 2.1x
Keros Therapeutics, Inc. KROS ██% $335M 3.9x 1.1x
Korro Bio, Inc. KRRO ██% $153M -7.9x 1.6x
Pasithea Therapeutics Corp. KTTA ██% $18M -73.5x 1.5x
Kura Oncology, Inc. KURA ██% $709M -4.5x 4.1x
Kezar Life Sciences, Inc. KZR ██% $47M -3.2x 0.6x
Legend Biotech Corp LEGN ██% $3.43B x x
Lexaria Bioscience Corp. LEXX ██% $18M -29.3x 3.7x
Lifecore Biomedical, Inc. \De\ LFCR ██% $150M x 112.2x
Lifevantage Corp LFVN ██% $55M 7.0x 1.7x
Ligand Pharmaceuticals Inc LGND ██% $3.99B 32.0x 3.9x
Longeveron Inc. LGVN ██% $26M -0.5x 4.6x
Lianbio LIANY ██% $19M x 0.1x
Lftd Partners Inc. LIFD ██% $4M 56.1x 0.1x
Lipella Pharmaceuticals Inc. LIPO ██% $730K -3.3x 0.5x
Lixte Biotechnology Holdings, Inc. LIXT ██% $26M -0.9x 5.3x
Lixte Biotechnology Holdings, Inc. LIXTW ██% $130K x 0.0x
Eli Lilly & Co LLY ██% $810.28B 39.3x 30.5x
Lipocine Inc. LPCN ██% $43M -2.6x 2.9x
Cypherpunk Technologies Inc. LPTX ██% $94M -1.1x 35.1x
Liquidia Corp LQDA ██% $3.07B -7.2x 68.6x
Larimar Therapeutics, Inc. LRMR ██% $475M -0.8x 6.1x
Lisata Therapeutics, Inc. LSTA ██% $44M -1.0x 3.0x
Lantern Pharma Inc. LTRN ██% $26M -2.4x 2.7x
Lava Therapeutics Nv LVTX ██% $46M x 3.6x
Lexicon Pharmaceuticals, Inc. LXRX ██% $729M -1.2x 6.8x
Lyell Immunopharma, Inc. LYEL ██% $428M -1.1x 1.7x
Maia Biotechnology, Inc. MAIA ██% $84M -1.4x 35.6x
Mustang Bio, Inc. MBIO ██% $6M -0.1x 0.7x
Moleculin Biotech, Inc. MBRX ██% $11M -2.3x 253.7x
Mbx Biosciences, Inc. MBX ██% $1.34B x 3.6x
Seres Therapeutics, Inc. MCRB ██% $79M 13.9x 1.8x
Medicus Pharma Ltd. MDCX ██% $12M x x
Medicus Pharma Ltd. MDCXW ██% $52M x x
Madrigal Pharmaceuticals, Inc. MDGL ██% $10.17B -5.7x 16.9x
Chrome Holding Co. MEHCQ ██% $96M x x
Macrogenics Inc MGNX ██% $173M -2.1x 3.1x
Mira Pharmaceuticals, Inc. MIRA ██% $44M -1.6x 5.8x
Mirum Pharmaceuticals, Inc. MIRM ██% $5.83B -20.0x 18.5x
Milestone Pharmaceuticals Inc. MIST ██% $99M -2.0x 2.4x
Moonlake Immunotherapeutics MLTX ██% $1.20B -50.8x 4.0x
Mineralys Therapeutics, Inc. MLYS ██% $1.87B -4.5x 2.9x
Mannkind Corp MNKD ██% $705M 120.2x 40.2x
Medicinova Inc MNOV ██% $71M -7.1x 1.7x
Monopar Therapeutics MNPR ██% $368M -3.0x 2.6x
Mereo Biopharma Group Plc MREO ██% $53M x 1.3x
Merck & Co., Inc. MRK ██% $289.91B 15.9x 5.5x
Marker Therapeutics, Inc. MRKR ██% $21M -0.6x 1.3x
Mersana Therapeutics, Inc. MRSN ██% $145M -3.4x -1.4x
Merus N.V. MRUS ██% $6.83B -13.5x 8.8x
Maravai Lifesciences Holdings, Inc. MRVI ██% $1.13B -5.6x 5.3x
Matinas Biopharma Holdings, Inc. MTNB ██% $4M -1.7x 0.6x
Metsera, Inc. MTSR ██% $7.41B x 22.0x
Metavia Inc. MTVA ██% $4M -0.5x 0.7x
Mural Oncology Plc MURA ██% $35M x 0.6x
Mainz Biomed N.V. MYNZ ██% $7M x x
Newamsterdam Pharma Co N.V. NAMS ██% $3.44B x 5.0x
Newamsterdam Pharma Co N.V. NAMSW ██% $2.59B x 3.6x
Natures Sunshine Products Inc NATR ██% $417M 21.4x 2.6x
Novabay Pharmaceuticals, Inc. NBY ██% $38M 8.0x 34.1x
Nucana Plc NCNA ██% $7M x x
Minerva Neurosciences, Inc. NERV ██% $340M -0.8x 42.6x
Neuphoria Therapeutics Inc. NEUP ██% $25M x 0.8x
Neurogene Inc. NGNE ██% $324M -7.3x 1.2x
Nika Pharmaceuticals, Inc NIKA ██% $786M x 192879.0x
Nektar Therapeutics NKTR ██% $2.10B -1.2x 23.4x
Nkarta, Inc. NKTX ██% $152M -1.3x 0.5x
Newcelx Ltd. NLSP ██% $54M x 98.9x
Newcelx Ltd. NLSPW ██% $120K x 0.2x
Nanoviricides, Inc. NNVC ██% $21M -2.1x 1.9x
Nurix Therapeutics, Inc. NRIX ██% $1.47B -7.4x 2.7x
Neurosense Therapeutics Ltd. NRSN ██% $24M x x
Nrx Pharmaceuticals, Inc. NRXP ██% $62M -0.6x 8.4x
Neonc Technologies Holdings, Inc. NTHI ██% $216M x x
Nuvation Bio Inc. NUVB ██% $1.46B -1.2x 4.8x
Nuvalent, Inc. NUVL ██% $6.99B -30.9x 5.6x
Nuvectis Pharma, Inc. NVCT ██% $223M -3.9x 12.1x
Novartis Ag NVS ██% $283.57B x x
Northwest Biotherapeutics Inc NWBO ██% $319M x x
Nexien Biopharma, Inc. NXEN ██% $10K x x
Nextcure, Inc. NXTC ██% $43M -0.5x 1.2x
Ocean Biomedical, Inc. OCEA ██% $190K -0.3x 0.1x
Ocular Therapeutix, Inc OCUL ██% $1.82B -8.2x 2.8x
Oragenics Inc OGEN ██% $3M -0.1x 0.4x
Organigram Global Inc. OGI ██% $192M x x
Organon & Co. OGN ██% $1.61B 8.6x 2.2x
Onkure Therapeutics, Inc. OKUR ██% $52M -6.9x 0.9x
Olema Pharmaceuticals, Inc. OLMA ██% $1.20B -4.0x 2.5x
Omeros Corp OMER ██% $743M -4.2x 36.2x
Beone Medicines Ltd. ONC ██% $32.27B 112.5x 7.4x
Onconetix, Inc. ONCO ██% $820K -0.3x 0.0x
Oncolytics Biotech Inc ONCY ██% $103M x x
Opko Health, Inc. OPK ██% $868M -3.5x 0.7x
Organogenesis Holdings Inc. ORGO ██% $312M 8.4x 1.0x
Orgenesis Inc. ORGS ██% $3M 0.9x 0.2x
Oric Pharmaceuticals, Inc. ORIC ██% $1.29B -4.2x 3.4x
Oruka Therapeutics, Inc. ORKA ██% $2.09B x 4.4x
Oramed Pharmaceuticals Inc. ORMP ██% $139M 3.2x 0.7x
Os Therapies Inc OSTX ██% $48M x 13.2x
Oncotelic Therapeutics, Inc. OTLC ██% $18M x 1.9x
Ovid Therapeutics Inc. OVID ██% $367M -2.6x 2.8x
One World Products, Inc. OWPC ██% $880K x 0.8x
Phibro Animal Health Corp PAHC ██% $2.32B 25.1x 7.0x
Prestige Consumer Healthcare Inc. PBH ██% $3.01B 16.1x 1.7x
Psyence Biomedical Ltd. PBM ██% $6M x x
Puma Biotechnology, Inc. PBYI ██% $323M 10.4x 2.5x
Pacira Biosciences, Inc. PCRX ██% $964M 137.0x 1.4x
Processa Pharmaceuticals, Inc. PCSA ██% $6M -0.5x 1.1x
Procyon Corp PCYN ██% $980K x 0.4x
Pds Biotechnology Corp PDSB ██% $33M -1.7x 3.4x
Pepgen Inc. PEPG ██% $348M -1.6x 2.4x
Pfizer Inc PFE ██% $154.61B 19.9x 1.8x
Precigen, Inc. PGEN ██% $1.15B -1.4x 27.4x
Phathom Pharmaceuticals, Inc. PHAT ██% $748M -1.6x 42.5x
Phio Pharmaceuticals Corp. PHIO ██% $15M -0.8x 0.7x
Pharvaris N.V. PHVS ██% $1.71B x x
Protokinetix, Inc. PKTX ██% $3M x 12.0x
Plandai Biotechnology, Inc. PLPL ██% $4M x 14.6x
Pliant Therapeutics, Inc. PLRX ██% $82M -4.5x 0.5x
Polomar Health Services, Inc. PMHS ██% $2M x 0.2x
Promis Neurosciences Inc. PMN ██% $157M -2.1x 17.1x
Pmv Pharmaceuticals, Inc. PMVP ██% $75M -1.6x 0.7x
Purple Biotech Ltd. PPBT ██% $4M x x
Propanc Biopharma, Inc. PPCB ██% $2M x 0.2x
Praxis Precision Medicines, Inc. PRAX ██% $7.81B -4.0x 8.9x
Prf Technologies Ltd. PRFX ██% $2M x 0.3x
Perrigo Co Plc PRGO ██% $1.35B -27.6x 0.5x
Prelude Therapeutics Inc PRLD ██% $208M -0.5x 3.0x
Prophase Labs, Inc. PRPH ██% $360K -0.5x 0.1x
Proqr Therapeutics N.V. PRQR ██% $162M x x
Prothena Corp Public Ltd Co PRTA ██% $462M -12.4x 1.7x
Ptc Therapeutics, Inc. PTCT ██% $5.38B 7.9x 3739.4x
Protagonist Therapeutics, Inc PTGX ██% $5.99B 119.5x 9.7x
Protagenic Therapeutics, Inc.\New PTIX ██% $1M -2.8x 1.3x
Palatin Technologies Inc PTNT ██% $17M x 43.1x
Petros Pharmaceuticals, Inc. PTPI ██% $300K -0.1x 0.1x
Pulmatrix, Inc. PULM ██% $8M -1.8x 2.0x
Provectus Biopharmaceuticals, Inc. PVCT ██% $23M x 6.5x
Palvella Therapeutics, Inc. PVLA ██% $1.66B x 43.0x
Pyxis Oncology, Inc. PYXS ██% $89M -1.3x 1.7x
Aixcrypto Holdings, Inc. QLGN ██% $8M -1.3x 0.2x
Quoin Pharmaceuticals, Ltd. QNRX ██% $13M x 5.2x
Quantum Biopharma Ltd. QNTM ██% $19M x x
Q32 Bio Inc. QTTB ██% $103M 3.5x 2.5x
Uniqure N.V. QURE ██% $992M -2.8x 5.0x
Radiopharm Theranostics Ltd RADX ██% $32M x x
Rani Therapeutics Holdings, Inc. RANI ██% $138M -1.3x 69.3x
Rapport Therapeutics, Inc. RAPP ██% $1.43B x 3.0x
Rapt Therapeutics, Inc. RAPT ██% $1.56B -0.4x 10.3x
Ultragenyx Pharmaceutical Inc. RARE ██% $2.00B -7.0x 218.2x
Rocket Pharmaceuticals, Inc. RCKT ██% $489M -4.8x 1.8x
Arcus Biosciences, Inc. RCUS ██% $2.69B -5.5x 4.3x
Dr Reddys Laboratories Ltd RDY ██% $11.54B x x
Regeneron Pharmaceuticals, Inc. REGN ██% $78.54B 17.4x 2.5x
Revelation Biosciences, Inc. REVB ██% $4M -0.1x 0.5x
Rafael Holdings, Inc. RFL ██% $65M -0.9x 0.8x
Regen Biopharma Inc RGBP ██% $110K x 1.3x
Regen Biopharma Inc RGBPP ██% $470K x x
Rigel Pharmaceuticals Inc RIGL ██% $484M 1.3x 1.2x
Relmada Therapeutics, Inc. RLMD ██% $475M -0.1x 5.5x
Rallybio Corp RLYB ██% $53M -0.7x 0.8x
Retrieve Medical Holdings, Inc. RMHI ██% $26M x 337.7x
Rockwell Medical, Inc. RMTI ██% $42M -17.1x 1.1x
Avidity Biosciences, Inc. RNA ██% $204M -12.2x 0.1x
Cartesian Therapeutics, Inc. RNAC ██% $162M -2.1x 215.2x
Transcode Therapeutics, Inc. RNAZ ██% $7M -0.2x 5.0x
Rein Therapeutics, Inc. RNTX ██% $31M x 0.7x
Renovorx, Inc. RNXT ██% $53M -3.4x 6.6x
Roivant Sciences Ltd. ROIV ██% $19.52B 1.8x 4.6x
Royalty Pharma Plc RPRX ██% $26.92B 34.9x 4.2x
Repare Therapeutics Inc. RPTX ██% $114M -2.1x 1.0x
Rest Ez Inc. RTEZ ██% $1.93B x 6425307.7x
Rapid Therapeutic Science Laboratories, Inc. RTSL ██% $110K 1.9x 0.3x
Reviva Pharmaceuticals Holdings, Inc. RVPH ██% $12M -4.1x 2.7x
Rhythm Pharmaceuticals, Inc. RYTM ██% $5.61B -20.3x 40.3x
Rezolute, Inc. RZLT ██% $233M -3.9x 1.8x
Filana Therapeutics, Inc. SAVA ██% $101M -1.9x 1.2x
Sunshine Biopharma Inc. SBFM ██% $5M -0.6x 0.2x
Scienture Holdings, Inc. SCNX ██% $18M 2.9x 0.2x
Scpharmaceuticals Inc. SCPH ██% $302M -2.0x -50.9x
Scorpius Holdings, Inc. SCPX ██% $790K 0.0x 0.0x
Scynexis Inc SCYX ██% $39M -2.4x 0.8x
Schrodinger, Inc. SDGR ██% $893M -7.8x 2.5x
Septerna, Inc. SEPN ██% $1.10B x 2.9x
Serina Therapeutics, Inc. SER ██% $32M 22.6x 17.9x
Sagimet Biosciences Inc. SGMT ██% $152M x 1.4x
Shuttle Pharmaceuticals Holdings, Inc. SHPH ██% $5M x 3.7x
Siga Technologies Inc SIGA ██% $361M 15.5x 1.8x
Silo Pharma, Inc. SILO ██% $5M x 1.0x
Sionna Therapeutics, Inc. SION ██% $1.69B x 5.5x
Skinvisible, Inc. SKVI ██% $2M x x
Skye Bioscience, Inc. SKYE ██% $21M -0.7x 1.1x
Sol-Gel Technologies Ltd. SLGL ██% $227M x 9.9x
Silence Therapeutics Plc SLN ██% $318M x 5.1x
Silence Therapeutics Plc SLNCF ██% $213M x 2.9x
Soleno Therapeutics Inc SLNO ██% $1.75B 83.8x 3.9x
Salarius Pharmaceuticals, Inc. SLRX ██% $2M -0.5x 0.4x
Sellas Life Sciences Group, Inc. SLS ██% $885M -1.0x 19.4x
Summit Therapeutics Inc. SMMT ██% $13.61B 104.1x 20.7x
Syndax Pharmaceuticals Inc SNDX ██% $2.09B -4.1x 32.3x
Soligenix, Inc. SNGX ██% $12M -1.8x 1.6x
Sibannac, Inc. SNNC ██% $830K x 1.8x
Sensei Biotherapeutics, Inc. SNSE ██% $38M -0.4x 1.6x
Sanofi SNY ██% $106.00B x x
Sonnet Biotherapeutics Holdings, Inc. SONN ██% $4M -1.6x 29.5x
Spruce Biosciences, Inc. SPRB ██% $95M -0.4x 2.2x
Scisparc Ltd. SPRC ██% $2M x x
Spero Therapeutics, Inc. SPRO ██% $139M -17.8x 5.2x
Ars Pharmaceuticals, Inc. SPRY ██% $799M -23.5x 7.0x
Sarepta Therapeutics, Inc. SRPT ██% $2.38B 162.5x 2.1x
Stoke Therapeutics, Inc. STOK ██% $2.03B 45.5x 5.8x
Shattuck Labs, Inc. STTK ██% $441M x 5.4x
Supernus Pharmaceuticals, Inc. SUPN ██% $2.85B 46.0x 2.7x
Savara Inc SVRA ██% $1.08B -8.2x 5.3x
60 Degrees Pharmaceuticals, Inc. SXTP ██% $4M -0.6x 0.8x
Synlogic, Inc. SYBX ██% $8M 3.6x 0.7x
Spyre Therapeutics, Inc. SYRE ██% $3.36B -0.7x 4.7x
Syros Pharmaceuticals, Inc. SYRS ██% $20K -0.1x -0.4x
Takeda Pharmaceutical Co Ltd TAK ██% $57.84B x x
Theravance Biopharma, Inc. TBPH ██% $780M 7.4x 2.6x
Alaunos Therapeutics, Inc. TCRT ██% $7M -1.0x 2.4x
Telomir Pharmaceuticals, Inc. TELO ██% $44M x 7.4x
Tenax Therapeutics, Inc. TENX ██% $237M -14.9x 2.4x
Terns Pharmaceuticals, Inc. TERN ██% $5.76B -5.1x 20.3x
Teva Pharmaceutical Industries Ltd TEVA ██% $34.11B 24.2x 4.3x
Teva Pharmaceutical Industries Ltd TEVJF ██% $38.09B 53.4x 5.3x
Tg Therapeutics, Inc. TGTX ██% $4.67B 10.4x 7.2x
Canton Strategic Holdings, Inc. THAR ██% $186M x 30.2x
Talphera, Inc. TLPH ██% $39M -2.3x 2.3x
Telix Pharmaceuticals Ltd TLX ██% $2.87B x x
Tango Therapeutics, Inc. TNGX ██% $2.84B -2.8x 8.2x
Tonix Pharmaceuticals Holding Corp. TNXP ██% $191M 0.0x 0.8x
Theriva Biologics, Inc. TOVX ██% $10M -0.4x 0.2x
Tempest Therapeutics, Inc. TPST ██% $23M -0.5x 3.7x
Traws Pharma, Inc. TRAW ██% $17M -0.6x 1.5x
Entrada Therapeutics, Inc. TRDA ██% $460M 6.9x 1.5x
Trevi Therapeutics, Inc. TRVI ██% $1.44B -6.1x 7.9x
Trevena Inc TRVN ██% $260K -1.3x 1.5x
Tvardi Therapeutics, Inc. TVRD ██% $31M x 1.1x
Travere Therapeutics, Inc. TVTX ██% $2.45B x 21.3x
Therapeuticsmd, Inc. TXMD ██% $27M 538.2x 1.0x
Tyra Biosciences, Inc. TYRA ██% $1.99B -9.5x 7.7x
Unicycive Therapeutics, Inc. UNCY ██% $138M -0.9x 3.7x
Upstream Bio, Inc. UPB ██% $468M x 1.2x
Urogen Pharma Ltd. URGN ██% $894M -2.5x 35.0x
United Therapeutics Corp UTHR ██% $23.66B 17.7x 3.3x
Vaccinex, Inc. VCNX ██% $3M -0.1x 0.4x
Vera Therapeutics, Inc. VERA ██% $2.58B -20.4x 4.3x
Veru Inc. VERU ██% $39M -0.8x 2.1x
Vicapsys Life Sciences, Inc. VICP ██% $49M x x
Vincerx Pharma, Inc. VINC ██% $70K -0.2x 0.0x
Viracta Therapeutics, Inc. VIRX ██% $390K -0.2x 0.2x
Viking Therapeutics, Inc. VKTX ██% $3.81B -67.5x 6.0x
Vanda Pharmaceuticals Inc. VNDA ██% $506M -16.1x 1.6x
Verrica Pharmaceuticals Inc. VRCA ██% $98M -0.5x 4.0x
Viridian Therapeutics, Inc.\De VRDN ██% $2.89B -4.5x 4.0x
Vireo Growth Inc. VREOF ██% $348M x 1.4x
Verona Pharma Plc VRNA ██% $73.55B -185.1x 264.3x
Virpax Pharmaceuticals, Inc. VRPX ██% $160K 0.0x -19.5x
Vertex Pharmaceuticals Inc / Ma VRTX ██% $115.56B 29.2x 6.2x
Verastem, Inc. VSTM ██% $447M -6.5x 7.8x
Vistagen Therapeutics, Inc. VTGN ██% $22M -0.1x 0.4x
Viatris Inc VTRS ██% $16.17B -29.5x 0.0x
Vtv Therapeutics Inc. VTVT ██% $0.00M -3.3x -7.5x
Ventyx Biosciences, Inc. VTYX ██% $999M -1.0x 5.2x
Vyne Therapeutics Inc. VYNE ██% $21M -0.4x 0.7x
Whitehawk Therapeutics, Inc. WHWK ██% $180M x 1.3x
Wave Life Sciences Ltd. WVE ██% $2.31B -22.2x 4.5x
Xenetic Biosciences, Inc. XBIO ██% $7M x 1.0x
Xbiotech Inc. XBIT ██% $72M -3.5x 0.5x
Exicure, Inc. XCUR ██% $29M -1.9x 7.5x
Xenon Pharmaceuticals Inc. XENE ██% $5.30B -15.4x 9.1x
Xeris Biopharma Holdings, Inc. XERS ██% $881M 1590.2x 64.4x
Xilio Therapeutics, Inc. XLO ██% $558M -0.5x 79.0x
Xencor Inc XNCR ██% $891M -8.4x 1.4x
Xoma Royalty Corp XOMA ██% $358M 11.3x 4.3x
Xoma Royalty Corp XOMAO ██% $312M 14.4x 3.6x
Xoma Royalty Corp XOMAP ██% $326M 15.1x 3.7x
Xtl Biopharmaceuticals Ltd XTLB ██% $26M x x
Zenas Biopharma, Inc. ZBIO ██% $1.21B x 5.0x
Zai Lab Ltd ZLAB ██% $2.02B -95.2x 2.8x
Zentalis Pharmaceuticals, Inc. ZNTL ██% $165M -1.4x 0.7x
Zomedica Corp. ZOMDF ██% $132M x 1.1x
Zoetis Inc. ZTS ██% $49.59B 18.6x 14.9x
Zevra Therapeutics, Inc. ZVRA ██% $519M 6.2x 3.4x
Zyversa Therapeutics, Inc. ZVSA ██% $2M x 0.3x
Zymeworks Inc. ZYME ██% $1.75B -8.3x 6.5x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Gsk Plc Stock Forecast

How accurate are Gsk Plc stock predictions?

Our AI model shows a 8500% Spearman correlation coefficient for GSK predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Gsk Plc stock price forecasts?

Our analysis considers Gsk Plc's financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Gsk Plc a good investment in 2025?

Based on our AI analysis, Gsk Plc shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Gsk Plc forecasts updated?

Gsk Plc stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

My Portfolio

Investment Dashboard

Loading your portfolio...